Welcome to the New Value Research! Two routes to the Nifty 50 Three global funds reopen to new SIPs Thirty Funds to Six. A Two-Year Exit Plan. Symbiotec Pharmalab IPO: Is the issue worth subscribing to? Should I move my Rs 1.2 crore portfolio to a PMS? Retiring soon and in the top slab. Switch to direct or wait? A fund is marked for exit. Sell all at once or gradually? Breaking the habit Growth that goes nowhere 10 growth stocks that compound The NPS learns its ABCs, and so should you How Much Is Too Much in One Fund? Your index fund may stop borrowing money it never needed One global fund reopens to new SIPs Aggressive Hybrid VS Balanced Advantage Funds A Rs 10 fund may look cheap. It isn't: NAV illusion decoded The growth the market missed Fortis vs Aster: Two hospital chains, two growth bets Rentomojo IPO: Real profits, rich price Rs 96 of every Rs 213 you pay for this ETF buys nothing Are debt funds taxed as FDs now? Up 41 per cent in a week. The fund inside it fell 3 per cent Why is one Birla entry rattling India's cable makers? The Premium My Father Sold Debt funds vs FDs: Same tax rate, very different outcomes The first SIP at 40: what 20 years can still build Hero Motors IPO: Is the EV story worth the price? When the buyer is also the seller NSE IPO: A business that is hard to fault Three shops, same profit. What sets them apart? The UPI fee isn't your problem. Your expense ratio is. ₹1.8 crore, retiring in 2 years. Exit equity? Same 100 stocks. One fund made 53 per cent, four made 30 Need money? How to sell smart. 10 promising new funds The three-year wait The tax rate is the same. The compounding isn't Nesco: A gold mine that may take too long to dig Elevate Campuses: Interesting business, complicated IPO